Insmed INSM Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 308.5%-0.9pp | 309.3%-4.5pp | 313.9%+5.8pp | 308.1%+4.8pp | |
| Operating margin | -974.4%-36.5pp | -937.8%-15.9pp | -921.9%-207pp | -715%+58.8pp | |
| Net margin | -1,001.1%-16.9pp | -984.3%-10.4pp | -973.8%-193pp | -781%+104pp | |
| EBITDA margin | -962.5%-35.3pp | -927.2%-13.1pp | -914.1%-211pp | -703%+50.0pp | |
| Free cash flow margin | -787.6%-41.8pp | -745.8%-26.5pp | -719.3%-49.9pp | -669.4%+103pp | |
| Returns | |||||
| Return on assets | -229.8%-19.0pp | -210.9%-1.5pp | -209.4%-54.6pp | -154.7%+9.4pp | |
| Return on invested capital | -814.9%+233pp | -1,047.6%-315pp | -732.7%-189pp | -544.1%+128pp | |
| Efficiency | |||||
| Asset turnover | 0.9×+0.1× | 0.9×0.0× | 0.9×+0.1× | 0.8×0.0× | |
| Inventory turnover | 4×+0.4× | 3.6×+0.3× | 3.3×+0.1× | 3.3×-0.1× | |
| Liquidity | |||||
| Current ratio | 21×+4.7× | 16.3×-3.7× | 20×-3.3× | 23.3×-8.0× | |
| Quick ratio | 19.7×+4.4× | 15.2×-3.2× | 18.5×-2.8× | 21.3×-7.6× | |
| Cash ratio | 7.7×+0.3× | 7.4×-5.3× | 12.8×-3.7× | 16.4×-10.7× | |
| Leverage | |||||
| Debt-to-equity | 13.4×— | —— | —— | —— | |
| Debt-to-assets | 1.4×-1.4× | 2.8×-0.6× | 3.4×+0.4× | 3.1×+1.0× | |
| Interest coverage | -51.8×-14.0× | -37.8×+2.6× | -40.4×+19.4× | -59.8×-20.8× | |
| Per Share | |||||
| Book value per share | $15.33+833% | $1.64+128% | -$5.85-417% | $1.84-87.5% | |
| Valuation | |||||
| Market capitalization | $101.48B+170% | $37.52B+179% | $13.46B+25.9% | $10.69B-21.1% | |
| Enterprise value | $101.83B+160% | $39.24B+150% | $15.68B+31.2% | $11.95B-7.1% | |
| Price / sales | 216.1×+106× | 109.6×+61.8× | 47.9×+0.6× | 47.3×-30.4× | |
| Price / book | 237.8×— | —— | —— | —— | |
| EV / sales | 216.9×+102× | 114.7×+59.0× | 55.7×+2.8× | 52.9×-20.8× | |
| Free cash flow yield | -15.6%+16.6pp | -32.3%+29.6pp | -61.9%-4.7pp | -57.2%-16.9pp | |
| Earnings yield | -19.8%+22.3pp | -42.1%+41.0pp | -83.1%-16.7pp | -66.5%-20.2pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Insmed's profit margins?
- Insmed (INSM) runs a 81.8% gross margin and a -140.6% operating margin, with a -144.4% net margin.
- Where do Insmed's ratios come from?
- Every ratio is computed from Insmed's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
